In a pediatric patient with trisomy 13 who presents with a heart murmur on auscultation, which cardiac defect is most likely: atrial septal defect (ASD), ventricular septal defect (VSD), or coarctation of the aorta?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Likely Cardiac Defect in Trisomy 13

The answer is B. Ventricular Septal Defect (VSD) is the most likely cardiac defect in a pediatric patient with trisomy 13 presenting with a heart murmur.

Reasoning Based on Evidence

VSD is the predominant cardiac defect in trisomy 13, occurring in approximately 77-80% of affected patients 1, 2. This makes it by far the most common structural heart abnormality you will encounter when examining these children.

Frequency of Cardiac Defects in Trisomy 13

The evidence hierarchy clearly demonstrates:

  • VSD: 77-80% - The overwhelming majority 2
  • Valvular anomalies: 100% in autopsy studies (but these may not all produce audible murmurs) 2
  • ASD (secundum type): 80% - Common but less likely to produce prominent murmurs 2
  • Patent ductus arteriosus: Variable frequency 2
  • Coarctation of aorta: Not specifically mentioned as common in trisomy 13

Clinical Context

Congenital heart disease is present in 57-80% of infants with trisomy 13 1. When a heart murmur is detected on auscultation in these patients, the statistical probability overwhelmingly favors VSD as the underlying defect.

The 2025 Pediatrics clinical guidance emphasizes that cardiac evaluation is essential in all trisomy 13 patients given the high prevalence of structural heart disease 1. The most recent research from 2024 confirms that isolated atrial/ventricular septal defects comprise 40% of CHD in trisomy 13 patients, with VSD being the dominant lesion 3.

Why Not the Other Options?

ASD (Option A): While secundum ASD occurs in approximately 80% of trisomy 13 cases 2, these defects typically produce softer, less prominent murmurs compared to VSDs. The classic fixed split S2 of ASD may be difficult to appreciate in a critically ill neonate.

Coarctation of aorta (Option C): This is not reported as a characteristic cardiac defect in trisomy 13. The evidence specifically associates coarctation more strongly with trisomy 18 (23% frequency) 3 and Turner syndrome 4, not trisomy 13.

Important Clinical Pitfalls

  • Don't assume all murmurs in trisomy 13 are benign - 57-80% have significant structural heart disease 1
  • Multiple defects often coexist - VSD frequently occurs with valvular abnormalities and ASD 2
  • Echocardiography is mandatory for definitive diagnosis in any trisomy 13 patient with a murmur 5

Diagnostic Workup

When you hear a murmur in a trisomy 13 patient:

  1. Obtain echocardiography immediately - Class I indication for syndromes associated with high incidence of CHD 5
  2. Assess for pulmonary hypertension - Develops in 57% of trisomy 13 patients with CHD 6
  3. Evaluate for multiple defects - VSD rarely occurs in isolation in these patients 2

The evidence strongly supports VSD as the correct answer, with a frequency nearly 4 times higher than what would be expected by chance alone in this specific genetic syndrome.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.